hosphatidylinositol 3-kinase (PI 3-kinase), a signaling molecule activated by insulin receptor substrate (IRS)-1, has a role in both insulin-stimulated glucose uptake and in basal glucose transporter recycling. PI 3-kinase is also responsible for phosphorylating phosphatidylinositol, PI-4-P, PI-4,5-P 2 , and PI-3,4,5-P 3 , w h i c h function as intracellular second messengers. The structure of PI 3-kinase is heterodimeric, consisting of a catalytic subunit (p110) and a regulatory subunit, which is one of several alternatively spliced products of the p85 gene (G R B 1) (1). Since inhibitors of PI 3-kinase block insulin-stimulated glucose uptake (2), we initially investigated the p85 gene as a candidate gene for the decrease in the rate of insulin-stimulated glucose uptake that is observed in Pima Indians before the onset of type 2 diabetes. However, our preliminary fin d i n g s indicate that a variation in p85 does not alter insulin-stimulated glucose uptake, but rather affects the acute insulin response in Pima women. In addition, since an association with the acute insulin response was only observed in women, we hypothesize that p85 may be differentially expressed in men and women.
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, a signaling molecule activated by insulin receptor substrate (IRS)-1, has a role in both insulin-stimulated glucose uptake and in basal glucose transporter recycling. PI 3-kinase is also responsible for phosphorylating phosphatidylinositol, PI-4-P, PI-4,5-P 2 , and PI-3,4,5-P 3 , w h i c h function as intracellular second messengers. The structure of PI 3-kinase is heterodimeric, consisting of a catalytic subunit (p110) and a regulatory subunit, which is one of several alternatively spliced products of the p85 gene (G R B 1) (1) . Since inhibitors of PI 3-kinase block insulin-stimulated glucose uptake (2), we initially investigated the p85 gene as a candidate gene for the decrease in the rate of insulin-stimulated glucose uptake that is observed in Pima Indians before the onset of type 2 diabetes. However, our preliminary fin d i n g s indicate that a variation in p85 does not alter insulin-stimulated glucose uptake, but rather affects the acute insulin response in Pima women. In addition, since an association with the acute insulin response was only observed in women, we hypothesize that p85 may be differentially expressed in men and women.
Sequence analysis of muscle cell cDNA from insulin-sensitive and insulin-resistant Pima subjects identified one previously reported missense polymorphism at codon 326 (AT G to ATA), which predicts a Met to an Ile substitution (3). This polymorphism was genotyped in 1,182 Pima subjects and in 53 North American Caucasians (Centre d'Etude Polymorphism Humain [CEPH] ) by sequencing of a 104 base pair (bp) fragment of DNA amplified from this region of genomic DNA. The frequency of the Met-encoding allele was 0.75, and the frequency of the Ile-encoding allele was 0.25 in the Pima population. The frequency of this polymorphism was slightly lower in the CEPH samples (0.83 and 0.17 for the Met-and Ileencoding alleles, respectively). The allelic frequencies observed in the CEPH population were similar to those previously reported in a Danish Caucasian population (0.84 and 0.16) (3). All of the allelic frequencies were in Hardy-We i n b e r g equilibrium. A second nucleotide variation at codon 330 was also identified in all 1,182 Pima DNA samples and the 53 CEPH DNA samples. This codon (GAT, which encodes Asp) differed from the original published sequence of p85 ( A AT, which encodes Asn at codon 330) (4).
The prevalence of type 2 diabetes was assessed in individuals whose DNA had been genotyped for the polymorphism at codon 326 of p85 . In a group of 950 full-blooded Pima Indians (n = 400 men and 550 women), no association was found between the polymorphism and type 2 diabetes. S i m i l a r l y, analysis of the men alone did not indicate a difference in the prevalence of type 2 diabetes based on p85 genotype. However, a significant difference in the prevalence of type 2 diabetes was observed in Pima women based on p 8 5 genotype. The groups of women with genotypes that encode Met/Met (n = 305), or Met/Ile (n = 208), or Ile/Ile (n = 37), all had similar mean ages (47 ± 1, 44 ± 1, 45 ± 2 years) and mean BMIs (34 ± 0.5, 36 ± 0.6, 34 ± 1.3 kg/m 2 ), but the group of women homozygous for the Ile-encoding allele had a lower prevalence of type 2 diabetes: 49% of Ile/Ile women were diabetic, whereas 72% of Met/Met women and 71% of Met/Ile women were diabetic ( 2 = 8.6; df = 2; P < 0.02) (Fig. 1 ). The polymorphism in p85 was further analyzed in nondiabetic Pima women to determine its potential mode of action in i n fluencing diabetic status (Table 1) . Despite the role of PI 3-kinase in insulin-stimulated glucose uptake, the polymorphism in p85 was not associated with insulin sensitivity as measured by the hyperinsulinemic-euglycemic clamp technique (Table 1) . Instead, women with the Ile/Ile-encoding genotype had significantly higher acute insulin responses when compared with women with a Met/Met or Met/Ile-encoding genotype (P < 0.008) (Fig. 1) . A significant decrease in the 2-h postload glucose (P < 0.008) was also observed in women with the Ile/Ile-encoding genotype, presumably as a result of the increase in early insulin secretion ( Table 1) .
The association of a polymorphism in p85 with the acute insulin response suggests that the -cell is also a target for PI 3-kinase activity. Recently, PI-3,4,5-P 3 , the end product of PI 3-kinase phosphorylation of polyphosphoinositides, has been identified in islets (5) . Although significant levels of PI-3 , 4 , 5 -P 3 can be detected in -cells under nonstimulatory conditions, insulin secretagogues cause a rapid and transient increase in PI-3,4,5-P 3 levels, which peak at 2-5 min, corresponding to the acute insulin response (5). Data are means ± SE. Table shows clinical characteristics depicted in Fig. 1B . After obtaining written informed consent, Pima Indian volunteers from the Gila River Indian Community were admitted to the clinical research center for 10-12 days for metabolic testing. After a minimum of 3 days on a weight-maintaining diet, subjects received a 3-h, 75-g oral glucose tolerance test, and diabetic status was assessed using the World Health Organization criteria (7). On subsequent days, nondiabetic subjects underwent additional tests, which included underwater weighing to determine body composition and a two-step hyperinsulinemic clamp at physiological (M L o w , mean plasma insulin concentration = 865 ± 10 pmol/l) and maximally stimulating (M H i g h , mean plasma insulin concentration = 14,790 ± 335 pmol/l) insulin concentrations (8) . Tritiated glucose was infused to calculate glucose appearance rates before and during the clamp. Glucose disposal rates were normalized to kilograms of estimated metabolic body size (EMBS) (EMBS = fat-free mass + 17.7) (8). These studies were approved by the Institutional Review Board of the National Institutes of Diabetes and Digestive and Kidney Diseases and the Tribal Council of the Gila River Indian Community.
A B quency of Ile homozygotes was much lower (2%), and the men and women were combined in the analysis (3). We did not anticipate that an association between the polymorphism in the p85 gene and the acute insulin response would be observed only in women. Therefore, the present results should be considered as a hypothesis for further testing. Although we do not yet understand the underlying factors for this sexual dimorphism, pancreaticcells contain receptors for both progesterone and estradiol, and perfusion studies have shown that both the first and second phases of glucose-stimulated insulin release are reduced in the long-term absence of ovarian hormones, and the insulin responses can be partially or totally returned by supplementation with physiological doses of estradiol and progesterone. Whether the mechanism of insulin secretion in response to ovarian hormones has a role in the increased acute insulin response in women homozygous for the Ile variant of p85 remains to be determined.
The methionine at codon 326 in p85 is conserved among species, and therefore may have an important role in the function of this subunit. This codon is six residues away from the second of the two SH2 domains of p85 , and it has been suggested that the Met to Ile substitution may possibly affect binding of the SH2 domain, thereby altering the activity of PI 3-kinase (3). In Pima women, the less frequent Ile-encoding allele may be functioning as a "protective" gene by enhancing early insulin secretion via a PI 3-kinase-dependent pathw a y, thereby offsetting other metabolic determinants of type 2 diabetes in this population. However, knowledge of the islet regulation of the p85 gene, as well as the functional consequences of the polymorphism on PI 3-kinase activity, will be necessary to substantiate any hypotheses.
